Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient’ eXpectations and characterisTics: the TriNEXT Study
Condition(s):COPDLast Updated:March 13, 2024Recruiting